In the past few years, inroads have been made in the US, where pharmacogenetic testing, now covered by several insurance providers, has seen an increasing trend in its uptake [ 121 ].
← all excerpts
Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe.
1
—
—